Do interleukin-17 and interleukin-23 inhibitors alter the coagulation parameters in psoriasis patients?: A retrospective study
Archives of Dermatological Research · 2024
DOI: 10.1007/s00403-024-03369-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Simge Ünal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Dermatology and Venereology, Uşak University, Uşak Training and Research Hospital, Uşak, Turkey. Hauptthemen laut MEDLINE: Psoriasis, Interleukin-17, Antibodies, Monoclonal, Humanized, Interleukin-23. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Department of Dermatology and Venereology, Uşak University, Uşak Training and Research Hospital, Uşak, Turkey.
- Department of Dermatology, Girne Dr. Akcicek State Hosiptal, Kyrenia, Cyprus. tugcanyuksek6@gmail.com.
Zitieren
APA
Ünal, S., Yüksek, T., Öğüt, N. D., Yıldırım, S. K., Erbağcı, E., & Gökyayla, E. (2024). Do interleukin-17 and interleukin-23 inhibitors alter the coagulation parameters in psoriasis patients?: A retrospective study. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03369-3
Vancouver
Ünal S, Yüksek T, Öğüt ND, Yıldırım SK, Erbağcı E, Gökyayla E. Do interleukin-17 and interleukin-23 inhibitors alter the coagulation parameters in psoriasis patients?: A retrospective study. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-03369-3
BibTeX
@article{nal2024,
author = {Ünal, Simge and Yüksek, Tuğcan and Öğüt, Neslihan Demirel and Yıldırım, Sema Koç and Erbağcı, Ece and Gökyayla, Ece},
title = {Do interleukin-17 and interleukin-23 inhibitors alter the coagulation parameters in psoriasis patients?: A retrospective study},
journal = {Archives of Dermatological Research},
year = {2024},
doi = {10.1007/s00403-024-03369-3}
}
EUVIMED